Helen Parry

4.1k total citations
50 papers, 1.4k citations indexed

About

Helen Parry is a scholar working on Immunology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Helen Parry has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Genetics and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Helen Parry's work include Chronic Lymphocytic Leukemia Research (15 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Helen Parry is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Helen Parry collaborates with scholars based in United Kingdom, United States and Australia. Helen Parry's co-authors include Paul Moss, Guy Pratt, Jianmin Zuo, Rachel Bruton, Peter Hillmen, Tatjana Stanković, Kevin S. Channer, P. McLardy-Smith, Ivor Byren and Roger Gundle and has published in prestigious journals such as The Lancet, Blood and Nature Immunology.

In The Last Decade

Helen Parry

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Parry United Kingdom 20 358 303 268 267 234 50 1.4k
Anastasia Konstantinidou Greece 23 536 1.5× 236 0.8× 112 0.4× 120 0.4× 73 0.3× 81 1.6k
Magnus Hansson Sweden 22 281 0.8× 218 0.7× 560 2.1× 290 1.1× 59 0.3× 42 1.6k
Renée M. Ned United States 18 296 0.8× 112 0.4× 184 0.7× 71 0.3× 186 0.8× 31 1.3k
Christian Klemann Germany 18 257 0.7× 437 1.4× 366 1.4× 153 0.6× 57 0.2× 48 1.3k
Matthaios Speletas Greece 27 537 1.5× 214 0.7× 753 2.8× 209 0.8× 444 1.9× 106 2.0k
David G. Tubergen United States 22 317 0.9× 276 0.9× 354 1.3× 212 0.8× 145 0.6× 42 1.9k
Thierry Chinet France 30 493 1.4× 588 1.9× 200 0.7× 141 0.5× 557 2.4× 101 2.7k
Susanne M. Schmidt Germany 18 477 1.3× 404 1.3× 755 2.8× 103 0.4× 108 0.5× 30 1.9k
Ryan Shanley United States 20 356 1.0× 527 1.7× 113 0.4× 108 0.4× 169 0.7× 110 1.4k
Thomas Hundsberger Switzerland 20 346 1.0× 225 0.7× 117 0.4× 399 1.5× 671 2.9× 80 1.7k

Countries citing papers authored by Helen Parry

Since Specialization
Citations

This map shows the geographic impact of Helen Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Parry more than expected).

Fields of papers citing papers by Helen Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Parry. The network helps show where Helen Parry may publish in the future.

Co-authorship network of co-authors of Helen Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Parry. A scholar is included among the top collaborators of Helen Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Parry. Helen Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walewska, Renata, Toby A. Eyre, Adrian Bloor, et al.. (2025). 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 207(6). 2296–2313.
2.
3.
Parry, Helen, Rachel Bruton, Christine Stephens, et al.. (2022). Extended interval BNT162b2 vaccination enhances peak antibody generation. npj Vaccines. 7(1). 14–14. 59 indexed citations
4.
Jinks, Elizabeth, Tracey A. Haigh, Baksho Kaul, et al.. (2022). Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition. Nature Immunology. 23(12). 1726–1734. 19 indexed citations
5.
Parry, Helen, Rachel Bruton, Graham McIlroy, et al.. (2022). Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. Cell Reports Medicine. 3(9). 100739–100739. 6 indexed citations
6.
Parry, Helen, Graham McIlroy, Rachel Bruton, et al.. (2021). Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia. Blood Cancer Journal. 11(7). 136–136. 74 indexed citations
7.
Parry, Helen, Alexander C. Dowell, Jianmin Zuo, et al.. (2021). PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity. PLoS Pathogens. 17(3). e1009349–e1009349. 18 indexed citations
8.
Constantine, Andrew, Konstantinos Dimopoulos, Robert Tulloh, et al.. (2021). Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom. Journal of the American Heart Association. 11(1). e023035–e023035. 11 indexed citations
9.
Parry, Helen, Rachel Bruton, Christine Stephens, et al.. (2021). Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people. Immunity & Ageing. 18(1). 34–34. 38 indexed citations
10.
Zuo, Jianmin, Carrie R. Willcox, Fiyaz Mohammed, et al.. (2017). A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding. Science Signaling. 10(481). 23 indexed citations
11.
Davies, Nicholas, Marwan Kwok, Ceri Oldreive, et al.. (2017). Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts. Oncotarget. 8(27). 44749–44760. 10 indexed citations
12.
Parry, Helen, Jianmin Zuo, Guido Frumento, et al.. (2016). Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immunity & Ageing. 13(1). 1–1. 84 indexed citations
13.
Pratt, Guy, Peter Thomas, D. Alexander, et al.. (2016). Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival. Leukemia & lymphoma. 57(10). 2342–2350. 4 indexed citations
14.
Lang, Chim C., Daniel L. Levin, Mohapradeep Mohan, et al.. (2015). EFFECT OF GLYCAEMIC CONTROL ON OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE. Journal of the American College of Cardiology. 65(10). A886–A886. 2 indexed citations
15.
Koczula, Katarzyna M., Christian Ludwig, Rachel Hayden, et al.. (2015). Metabolic plasticity in CLL: adaptation to the hypoxic niche. Leukemia. 30(1). 65–73. 70 indexed citations
16.
Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2015). ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. Blood. 127(5). 582–595. 211 indexed citations
17.
Parry, Helen, Louise A. Donnelly, Natalie Van Zuydam, et al.. (2013). Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis. Cardiovascular Diabetology. 12(1). 109–109. 13 indexed citations
18.
Parry, Helen, et al.. (2011). Pandemic influenza A (H1N1) 2009 in a critical care and theatre setting: beliefs and attitudes towards staff vaccination. Journal of Hospital Infection. 78(4). 302–307. 12 indexed citations
19.
Bejon, Philip, Anthony R. Berendt, Bridget L. Atkins, et al.. (2010). Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. Journal of Antimicrobial Chemotherapy. 65(3). 569–575. 168 indexed citations
20.
Steeds, Richard P., Janine Fletcher, Helen Parry, et al.. (2002). The angiotensin-converting enzyme gene I/D polymorphism and heart rate variability following acute myocardial infarction. Clinical Autonomic Research. 12(2). 66–71. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Konstantinidou Breakdown of academic impact, for papers by Magnus Hansson Breakdown of academic impact, for papers by Renée M. Ned Breakdown of academic impact, for papers by Christian Klemann Breakdown of academic impact, for papers by Matthaios Speletas Breakdown of academic impact, for papers by David G. Tubergen Breakdown of academic impact, for papers by Thierry Chinet Breakdown of academic impact, for papers by Susanne M. Schmidt Breakdown of academic impact, for papers by Ryan Shanley Breakdown of academic impact, for papers by Thomas Hundsberger
Rankless by CCL
2026